The Latest from Mayo Clinic Laboratories
As the global reference laboratory for Mayo Clinic, Mayo Clinic Laboratories will help you advance patient care, strengthen your practice, and broaden access to specialized testing. Through our partnerships with clinicians at Mayo Clinic and health care providers around the world, we are able to offer the most sophisticated test catalog in the world. It is because of these daily collaborations that our subspecialized laboratories continue to be a critical component to patient care at Mayo Clinic.
|
|
Top impacts on the diagnostic industry in 2024William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, is a contributing author on Nasdaq.com. In his first penned article, Dr. Morice reflects on the diagnostic landscape in the post-pandemic environment and predicts trends that could influence the market in 2024. |
 |
New assay enhances and simplifies M-protein quantitationIn this test-specific episode of the “Answers From the Lab” podcast, David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories’ new MASS-FIX quantitation assay offers higher specificity for quantitating M-proteins in the blood, which are associated with multiple myeloma and other diseases. The new MASS-FIX quantitative assay further enhances the MASS-FIX mass spectrometry method developed at Mayo Clinic, which greatly improved screening for M-proteins. |
 |
Adrenal gland tumorsIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Stefan Grebe, M.D., Ph.D., co-director of the Clinical Mass Spectrometry and Test Development Laboratory in the Department of Laboratory Medicine and Pathology, and Irina Bancos, M.D., consultant in the Division of Endocrinology, Diabetes, Metabolism and Nutrition with a joint appointment in biochemistry and immunology. They discuss the diagnosis and management of adrenal gland tumors. |
 |
Test panel guides diagnosis of early onset IBDThe incidence of inflammatory bowel disease, or IBD, has rapidly increased — especially among children. In this test-specific episode of the “Answers From the Lab” podcast, Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories’ gene sequencing panel (Mayo ID: EOIBD) comprehensively evaluates patients with suspected monogenic early onset IBD. |
|
|
Emerging and reemerging diseasesIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss current activity of infectious diseases. |
Education Program
24th International Surgical Pathology Symposium
May 7-10, 2024 | Dublin, Ireland. The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical histories, examine digital images, and formulate differential diagnoses. Case discussions highlight pathologic findings that characterize entities within the differential diagnoses.
How to Order Testing
Many hospitals across the country have already established an account with Mayo Clinic Laboratories. Please click on the links below to register for an account or sign-in.
Registration for an account takes less than 10 minutes, and new accounts are typically processed and available in one business day. Once registered, sign in and locate the test in the Test Catalog and click the “Order This Test” button. Follow the prompts to provide billing and contact information. Print the test requisition form to ship with the specimen.
More from Mayo Clinic Laboratories
Want to read more about what’s happening at our labs? Visit our blog!